drugset / Trial / NCT05077462

A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy Volunteers

NCT05077462

Phase 1 Unknown 60 enrolled AJU Pharm Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate the safety and pharmacokinetic characteristics of AJU-C52H in healthy adults

Timeline

Start
2021-09-17
Primary completion
2022-04-30
Completion
2022-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg Oral
Subject Chlorthalidone Other / unclassified 25 mg Oral
Subject Valsartan Small molecule 160 mg Oral

Indications